NSETrading Window25 Jun 2026 · 25 Jun 2026, 12:28 pm
Trading Window
Mankind Pharma Limited · MANKIND
✦ AI Summary
Mankind Pharma Limited has informed the Exchange regarding the closure of the trading window for designated persons and their relatives due to the declaration of unaudited financial results for the quarter ending June 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
MANKIND1_25062026122828_Signed_Intimation_Trading_window_closure__2026-27-Q1.pdf
View document text
June 25, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of Closure of Trading Window
Ref.: Securities and Exchange Board of India (Prohibition of Insider Trading)
Regulations, 2015 and the Company’s ‘Code of Conduct for Prevention of
Insider Trading’
This is to inform you that pursuant to the provisions of the Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and
Company’s ‘Code of Conduct for Prevention of Insider Trading’, the trading window for
dealing in securities of the Company by the designated persons and/or their immediate relatives
and/or persons with whom such designated person shares a material financial relationship, will
be closed with effect from July 01, 2026 till 48 hours after the declaration of unaudited
standalone and consolidated financial results of the Company for the quarter ending on June
30, 2026.
The date of Board Meeting for declaration of the unaudited standalone and consolidated
financial results of the Company for the quarter ending on June 30, 2026 will be intimated in
due course.
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer